Vivos Therapeutics Inc stock is traded at $0.0958, with a volume of 738,031. It is up +2.24% in the last 24 hours and down -35.66% over the past month. Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Previous Close:
$0.0937
Open:
$0.0937
24h Volume:
738,031
Relative Volume:
1.01
Market Cap:
$1.93M
Revenue:
$19.57M
Net Income/Loss:
-$25.12M
P/E Ratio:
-
EPS:
-$2.31
Net Cash Flow:
-$19.71M
1W Performance:
-11.54%
1M Performance:
-35.66%
6M Performance:
-85.59%
1Y Performance:
-96.27%
1-Day Range:
$0.0937$0.0977
1-Week Range:
$0.092$0.1153
52-Week Range:
$0.092$2.72
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics IncSector
HealthcareIndustry
Medical DevicesPhone
(866)908-4867Address
7921 SOUTHPARK PLAZA,, LITTLETON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS